Physical and functional interactions between SH2 and SH3 domains of the Src family protein tyrosine kinase p59fyn. 1994

G Panchamoorthy, and T Fukazawa, and L Stolz, and G Payne, and K Reedquist, and S Shoelson, and Z Songyang, and L Cantley, and C Walsh, and H Band
Department of Rheumatology and Immunology, Joslin Diabetes Center, Boston, Massachusetts.

The Src family protein tyrosine kinases participate in signalling through cell surface receptors that lack intrinsic tyrosine kinase domains. All nine members of this family possess adjacent Src homology (SH2 and SH3) domains, both of which are essential for repression of the enzymatic activity. The repression is mediated by binding between the SH2 domain and a C-terminal phosphotyrosine, and the SH3 domain is required for this interaction. However, the biochemical basis of functional SH2-SH3 interaction is unclear. Here, we demonstrate that when the SH2 and SH3 domains of p59fyn (Fyn) were present as adjacent domains in a single protein, binding of phosphotyrosyl peptides and proteins to the SH2 domain was enhanced, whereas binding of a subset of cellular polypeptide ligands to the SH3 domain was decreased. An interdomain communication was further revealed by occupancy with domain-specific peptide ligands: occupancy of the SH3 domain with a proline-rich peptide enhanced phosphotyrosine binding to the linked SH2 domain, and occupancy of the SH2 domain with phosphotyrosyl peptides enhanced binding of certain SH3-specific cellular polypeptides. Second, we demonstrate a direct binding between purified SH2 and SH3 domains of Fyn and Lck Src family kinases. Heterologous binding between SH2 and SH3 domains of closely related members of the Src family, namely, Fyn, Lck, and Src, was also observed. In contrast, Grb2, Crk, Abl, p85 phosphatidylinositol 3-kinase, and GTPase-activating protein SH2 domains showed lower or no binding to Fyn or Lck SH3 domains. SH2-SH3 binding did not require an intact phosphotyrosine binding pocket on the SH2 domain; however, perturbations of the SH2 domain induced by specific high-affinity phosphotyrosyl peptide binding abrogated binding of the SH3 domain. SH3-SH2 binding was observed in the presence of proline-rich peptides or when a point mutation (W119K) was introduced in the putative ligand-binding pouch of the Fyn SH3 domain, although these treatments completely abolished the binding to p85 phosphatidylinositol 3-kinase and other SH3-specific polypeptides. These biochemical SH2-SH3 interactions suggest novel mechanisms of regulating the enzymatic activity of Src kinases and their interactions with other proteins.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D014443 Tyrosine A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin. L-Tyrosine,Tyrosine, L-isomer,para-Tyrosine,L Tyrosine,Tyrosine, L isomer,para Tyrosine
D051076 Proto-Oncogene Proteins c-fyn Src-family kinases that associate with T-CELL ANTIGEN RECEPTOR and phosphorylate a wide variety of intracellular signaling molecules. Proto-Oncogene Protein p60(fyn),c-fyn Protein,fyn Proto-Oncogene Proteins,Fyn Tyrosine Kinase,Protein-Tyrosine Kinase p59(fyn),Proto-Oncogene Protein c-fyn,Proto-Oncogene Protein c-syn,Proto-Oncogene Protein p59(fyn),Proto-Oncogene Protein p72(fyn),c-fyn Proto-Oncogene Proteins,p59 c-fyn Protein,p59(fyn) Protein,p60 c-fyn Protein,p60(fyn) Protein,p72 c-fyn Protein,p72(fyn) Protein,Proteins c-fyn, Proto-Oncogene,Proto Oncogene Protein c fyn,Proto Oncogene Protein c syn,Proto Oncogene Proteins c fyn,Proto-Oncogene Proteins, c-fyn,Proto-Oncogene Proteins, fyn,Tyrosine Kinase, Fyn,c fyn Proto Oncogene Proteins,c-fyn Protein, p59,c-fyn Protein, p60,c-fyn, Proto-Oncogene Protein,c-fyn, Proto-Oncogene Proteins,c-syn, Proto-Oncogene Protein,fyn Proto Oncogene Proteins,p59 c fyn Protein,p60 c fyn Protein,p72 c fyn Protein
D017853 Phosphotransferases (Alcohol Group Acceptor) A group of enzymes that transfers a phosphate group onto an alcohol group acceptor. EC 2.7.1.

Related Publications

G Panchamoorthy, and T Fukazawa, and L Stolz, and G Payne, and K Reedquist, and S Shoelson, and Z Songyang, and L Cantley, and C Walsh, and H Band
January 1994, Recent progress in hormone research,
G Panchamoorthy, and T Fukazawa, and L Stolz, and G Payne, and K Reedquist, and S Shoelson, and Z Songyang, and L Cantley, and C Walsh, and H Band
October 1992, Oncogene,
G Panchamoorthy, and T Fukazawa, and L Stolz, and G Payne, and K Reedquist, and S Shoelson, and Z Songyang, and L Cantley, and C Walsh, and H Band
January 1998, Biochemical and biophysical research communications,
G Panchamoorthy, and T Fukazawa, and L Stolz, and G Payne, and K Reedquist, and S Shoelson, and Z Songyang, and L Cantley, and C Walsh, and H Band
January 1998, The Journal of biological chemistry,
G Panchamoorthy, and T Fukazawa, and L Stolz, and G Payne, and K Reedquist, and S Shoelson, and Z Songyang, and L Cantley, and C Walsh, and H Band
April 1998, The Journal of biological chemistry,
G Panchamoorthy, and T Fukazawa, and L Stolz, and G Payne, and K Reedquist, and S Shoelson, and Z Songyang, and L Cantley, and C Walsh, and H Band
June 2009, Bioorganic & medicinal chemistry letters,
G Panchamoorthy, and T Fukazawa, and L Stolz, and G Payne, and K Reedquist, and S Shoelson, and Z Songyang, and L Cantley, and C Walsh, and H Band
April 1991, Cell,
G Panchamoorthy, and T Fukazawa, and L Stolz, and G Payne, and K Reedquist, and S Shoelson, and Z Songyang, and L Cantley, and C Walsh, and H Band
February 2011, The FEBS journal,
G Panchamoorthy, and T Fukazawa, and L Stolz, and G Payne, and K Reedquist, and S Shoelson, and Z Songyang, and L Cantley, and C Walsh, and H Band
April 2016, Protein science : a publication of the Protein Society,
G Panchamoorthy, and T Fukazawa, and L Stolz, and G Payne, and K Reedquist, and S Shoelson, and Z Songyang, and L Cantley, and C Walsh, and H Band
December 2000, Current drug targets,
Copied contents to your clipboard!